Mrv1909 12271913392D 7 6 0 0 0 0 999 V2000 -0.3546 0.0000 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 0.3592 0.4126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3592 1.2379 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.0733 0.0000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.0687 0.4126 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.3546 -0.8253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0733 -1.2379 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 0 0 0 0 3 2 2 0 0 0 0 4 2 1 0 0 0 0 5 1 1 0 0 0 0 1 6 1 6 0 0 0 7 6 1 0 0 0 0 M END > DB03275 > drugbank > N[C@@H](CS)C(N)=O > InChI=1S/C3H8N2OS/c4-2(1-7)3(5)6/h2,7H,1,4H2,(H2,5,6)/t2-/m0/s1 > YEDNBEGNKOANMB-REOHCLBHSA-N > C3H8N2OS > 120.173 > 120.035733578 > 2 > 15 > 0.9224223400878906 > 11.809892166597372 > 1 > 3 > 0 > 0 > (2R)-2-amino-3-sulfanylpropanamide > -1.4212043827229524 > 0 > 1 > 0 > 1 > 16.5558013814274 > 9.98160750758387 > 8.081761040640771 > 69.11 > 30.0458 > 2 > 1 > N-[(2S)-1-(1,3-benzothiazol-2-yl)-5-[(diaminomethylidene)amino]-1-oxopentan-2-yl]cyclopentanecarboxamide > 0 > DB03275 > EXPT01073 > experimental > Cysteinamide > 2-amino-3-mercapto-propionamide; L-Cysteinamide $$$$